Lasa Supergenerics Limited has informed the Exchange regarding Cessation of Mr Umesh Pawar as Executive Director of the company w.e.f. May 13, 2025.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics Limited has informed the exchanges that Mr. Umesh S Pawar (DIN: 10539778) has resigned from the position of Whole-Time Director of the company. The resignation is effective from the closing hours of May 13, 2025. According to the company, the reason for his resignation is health issues, and there are no other material reasons stated. The company has confirmed that no other details regarding relationships or new appointments were applicable in this case.
The departure of a Whole-Time Director due to health reasons is a routine leadership change, but shareholders should monitor whether the company announces a replacement soon to ensure continuity in operations and management.